818 related articles for article (PubMed ID: 25726383)
21. Transcatheter aortic valve implantation through carotid artery access under local anaesthesia.
Azmoun A; Amabile N; Ramadan R; Ghostine S; Caussin C; Fradi S; Raoux F; Brenot P; Nottin R; Deleuze P
Eur J Cardiothorac Surg; 2014 Oct; 46(4):693-8; discussion 698. PubMed ID: 24431170
[TBL] [Abstract][Full Text] [Related]
22. Long-Term Outcomes for Patients With Severe Symptomatic Aortic Stenosis Treated With Transcatheter Aortic Valve Implantation.
Codner P; Orvin K; Assali A; Sharony R; Vaknin-Assa H; Shapira Y; Schwartzenberg S; Bental T; Sagie A; Kornowski R
Am J Cardiol; 2015 Nov; 116(9):1391-8. PubMed ID: 26342515
[TBL] [Abstract][Full Text] [Related]
23. Balloon expandable transcatheter aortic valve implantation via the transfemoral route with or without pre-dilation of the aortic valve - rationale and design of a multicentre registry (EASE-IT TF).
Butter C; Bramlage P; Rudolph T; Jacobshagen C; Rothe J; Treede H; Kerber S; Frank D; Seilerova L; Schymik G
BMC Cardiovasc Disord; 2016 Nov; 16(1):223. PubMed ID: 27846807
[TBL] [Abstract][Full Text] [Related]
24. Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve.
Mussardo M; Latib A; Chieffo A; Godino C; Ielasi A; Cioni M; Takagi K; Davidavicius G; Montorfano M; Maisano F; Carlino M; Franco A; Covello RD; Spagnolo P; Grimaldi A; Alfieri O; Colombo A
JACC Cardiovasc Interv; 2011 Jul; 4(7):743-50. PubMed ID: 21777881
[TBL] [Abstract][Full Text] [Related]
25. Transaortic transcatheter aortic valve implantation using SAPIEN XT or SAPIEN 3 valves in the ROUTE registry.
Romano M; Frank D; Cocchieri R; Jagielak D; Bonaros N; Aiello M; Lapeze J; Laine M; Chocron S; Muir D; Eichinger W; Thielmann M; Labrousse L; Arne Rein K; Verhoye JP; Gerosa G; Baumbach H; Deutsch C; Bramlage P; Thoenes M; Bapat V
Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):757-764. PubMed ID: 28582580
[TBL] [Abstract][Full Text] [Related]
26. Incidence and predictors of left bundle branch block after transcatheter aortic valve implantation.
Aktug Ö; Dohmen G; Brehmer K; Koos R; Altiok E; Deserno V; Herpertz R; Autschbach R; Marx N; Hoffmann R
Int J Cardiol; 2012 Sep; 160(1):26-30. PubMed ID: 21458085
[TBL] [Abstract][Full Text] [Related]
27. Transcatheter Edwards Sapien XT valve in valve implantation in degenerated aortic bioprostheses via transfemoral access.
Greif M; Lange P; Mair H; Becker C; Schmitz C; Steinbeck G; Kupatt C
Clin Res Cardiol; 2012 Dec; 101(12):993-1001. PubMed ID: 22729757
[TBL] [Abstract][Full Text] [Related]
28. Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation - rationale and design of the FAST-TAVI registry.
Barbanti M; Baan J; Spence MS; Iacovelli F; Martinelli GL; Saia F; Bortone AS; van der Kley F; Muir DF; Densem CG; Vis M; van Mourik MS; Seilerova L; Lüske CM; Bramlage P; Tamburino C
BMC Cardiovasc Disord; 2017 Oct; 17(1):259. PubMed ID: 29017461
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Edwards Sapien XT versus Lotus Valve Devices in Terms of Electrophysiological Study Parameters in Patients Undergoing TAVI.
Eksik A; Yildirim A; Gul M; Aslan S; Tosu AR; Surgit O; Cakmak HA; Satilmisoglu MH; Akkaya E; Bakir I
Pacing Clin Electrophysiol; 2016 Oct; 39(10):1132-1140. PubMed ID: 27418419
[TBL] [Abstract][Full Text] [Related]
30. Incidence, predictive factors and haemodynamic consequences of acute stent recoil following transcatheter aortic valve implantation with a balloon-expandable valve.
Nombela-Franco L; Ribeiro HB; Urena M; Pasian S; Allende R; Doyle D; Delarochellière R; Delarochellière H; Laflamme L; Laflamme J; Jerez-Valero M; Côté M; Pibarot P; Larose E; Dumont E; Rodés-Cabau J
EuroIntervention; 2014; 9(12):1398-406. PubMed ID: 24064535
[TBL] [Abstract][Full Text] [Related]
31. Occurrence, fate and consequences of ventricular conduction abnormalities after transcatheter aortic valve implantation.
Houthuizen P; van der Boon RM; Urena M; Van Mieghem N; Brueren GB; Poels TT; Van Garsse LA; Rodés-Cabau J; Prinzen FW; de Jaegere P
EuroIntervention; 2014 Feb; 9(10):1142-50. PubMed ID: 24273252
[TBL] [Abstract][Full Text] [Related]
32. Conduction Abnormalities and Pacemaker Implantations After SAPIEN 3 Vs SAPIEN XT Prosthesis Aortic Valve Implantation.
Husser O; Kessler T; Burgdorf C; Templin C; Pellegrini C; Schneider S; Kasel AM; Kastrati A; Schunkert H; Hengstenberg C
Rev Esp Cardiol (Engl Ed); 2016 Feb; 69(2):141-8. PubMed ID: 26542175
[TBL] [Abstract][Full Text] [Related]
33. Predictors for permanent pacemaker implantation in patients undergoing transfemoral aortic valve implantation with the Edwards Sapien 3 valve.
Gonska B; Seeger J; Keßler M; von Keil A; Rottbauer W; Wöhrle J
Clin Res Cardiol; 2017 Aug; 106(8):590-597. PubMed ID: 28283746
[TBL] [Abstract][Full Text] [Related]
34. Impact of femoral artery puncture using digital subtraction angiography and road mapping on vascular and bleeding complications after transfemoral transcatheter aortic valve implantation.
El-Mawardy M; Schwarz B; Landt M; Sulimov D; Kebernik J; Allali A; Becker B; Toelg R; Richardt G; Abdel-Wahab M
EuroIntervention; 2017 Jan; 12(13):1667-1673. PubMed ID: 28106001
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of transcatheter aortic valve implantation with Edwards SAPIEN 3 and XT in smaller Asian anatomy.
Nakashima M; Watanabe Y; Hioki H; Nara Y; Nagura F; Hosogoe N; Kawashima H; Kataoka A; Otsuki S; Konno K; Kyono H; Yokoyama N; Kozuma K
Cardiovasc Interv Ther; 2018 Oct; 33(4):384-390. PubMed ID: 29185181
[TBL] [Abstract][Full Text] [Related]
36. Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Balloon-Expandable Transcatheter Heart Valve: A Single-Center Experience.
Husser O; Pellegrini C; Kessler T; Burgdorf C; Thaller H; Mayr NP; Ott I; Kasel AM; Schunkert H; Kastrati A; Hengstenberg C
JACC Cardiovasc Interv; 2015 Dec; 8(14):1809-16. PubMed ID: 26718512
[TBL] [Abstract][Full Text] [Related]
37. Survival, predictive factors, and causes of mortality following transcatheter aortic valve implantation.
Alassar A; Roy D; Valencia O; Brecker S; Jahangiri M
Innovations (Phila); 2013; 8(5):359-63. PubMed ID: 24346585
[TBL] [Abstract][Full Text] [Related]
38. Conduction dynamics after transcatheter aortic valve implantation and implications for permanent pacemaker implantation and early discharge: the CONDUCT-study.
van Gils L; Baart S; Kroon H; Rahhab Z; El Faquir N; Rodriguez Olivares R; Aga Y; Maugenest AM; Theuns DA; Boersma E; Szili Torok T; De Jaegere PP; Van Mieghem NM
Europace; 2018 Dec; 20(12):1981-1988. PubMed ID: 29688322
[TBL] [Abstract][Full Text] [Related]
39. Two-year outcomes for patients with severe symptomatic aortic stenosis treated with transcatheter aortic valve implantation.
Codner P; Assali A; Dvir D; Vaknin-Assa H; Porat E; Shapira Y; Kupershmidt M; Bental T; Battler A; Sagie A; Kornowski R
Am J Cardiol; 2013 May; 111(9):1330-6. PubMed ID: 23415022
[TBL] [Abstract][Full Text] [Related]
40. Standardized methodology for transfemoral transcatheter aortic valve replacement with the Edwards Sapien XT valve under fluoroscopy guidance.
Kasel AM; Shivaraju A; Schneider S; Krapf S; Oertel F; Burgdorf C; Ott I; Sumer C; Kastrati A; von Scheidt W; Thilo C
J Invasive Cardiol; 2014 Sep; 26(9):451-61. PubMed ID: 25198489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
